Chelsea Beiser
Payments from drug & device makers
Across 883 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Johnson & Johnson$2K
- Regeneron Healthcare Solutions, Inc.$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- QOL Medical, LLC$822
- plus $7K from 28 others
What the payments were for
- Consulting fees$8105%
- Food & beverage$17,12795%
- Education$490%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 213 | $3,854 |
| Takeda Pharmaceuticals U.S.A., Inc. | 89 | $1,757 |
| Johnson & Johnson(2 entities) | 78 | $1,705 |
| Regeneron Healthcare Solutions, Inc. | 31 | $1,600 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 89 | $1,425 |
| QOL Medical, LLC | 44 | $822 |
| Bristol Myers Squibb | 53 | $682 |
| Pfizer | 31 | $561 |
| Madrigal Pharmaceuticals | 17 | $524 |
| Redhill Biopharma Inc. | 27 | $466 |
| Ardelyx, Inc. | 20 | $440 |
| Braintree Laboratories, Inc. | 23 | $414 |
| Ironwood Pharmaceuticals, Inc | 26 | $405 |
| Nestle Healthcare Nutrition Inc. | 19 | $379 |
| Lilly USA, LLC | 16 | $353 |
| Janssen Scientific Affairs, LLC | 5 | $327 |
| Sanofi | 12 | $325 |
| Celltrion USA Inc. | 17 | $311 |
| Vivus LLC | 15 | $286 |
| E.r. Squibb & Sons, L.L.C. | 2 | $228 |
| Merck | 6 | $157 |
| Aimmune Therapeutics, Inc. | 8 | $137 |
| Phathom Pharmaceuticals, Inc. | 8 | $136 |
| Ferring Pharmaceuticals Inc. | 7 | $126 |
| Novo Nordisk | 7 | $123 |
| Gilead | 6 | $122 |
| Pharmacosmos Therapeutics Inc. | 3 | $95 |
| Exact Sciences | 3 | $58 |
| Evoke Pharma, Inc. | 3 | $56 |
| Lucid Diagnostics Inc. | 1 | $43 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Biocon Biologics Inc | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,986 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 34 | $32,208 |
| Mesalamine | 26 | $9,189 |
| Dexlansoprazole DrDexlansoprazole | 13 | $6,068 |
| Rabeprazole Sodium | 27 | $2,947 |
| Omeprazole | 115 | $1,718 |
| Colestipol Hcl | 25 | $1,407 |
| Pantoprazole Sodium | 30 | $431 |
| Famotidine | 18 | $280 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $3,854 | $32,20834 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,490 medical providers in Texas.
Other medical in Katy
- Radha BernanderKaty$74K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Courtney AldridgeSan Antonio$129K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.